Generate a tailored SOP for Dr. Paivi Ojala. Improve your application with a focused, well-structured draft.
Paivi Ojala is a distinguished researcher in the field of viral tumorigenesis, currently serving as the Chair of the Department of Medicine at Imperial College London. She joined Imperial in 2013 and has made significant contributions to understanding the molecular mechanisms underlying cancer biology, particularly through her work on virus-host cell interactions. Before her appointment at Imperial, she was a Research Professor at the Finnish Cancer Institute and obtained her Master's and PhD from the University of Helsinki. Ojala’s postdoctoral research included a prestigious fellowship at Yale University. Her interdisciplinary research group focuses on dissecting transcriptional regulatory networks in lymphatic endothelial cells, exploring how reprogrammed cells contribute to Kaposi sarcomagenesis. She has led groundbreaking research on the origin mechanisms of this disease, aiming to deepen our understanding of cancer development and the molecular regulation of Kaposi Sarcoma Herpesvirus (KSHV) replication, including both latent and lytic phases. Utilizing a range of molecular biology techniques, her group develops sophisticated cell models and employs large-scale image-based high-content screening platforms, complemented by in vivo mouse tumor models, to advance the field further.
Department of Medicine, Imperial College London • London, United Kingdom
Leading research and academic initiatives in viral tumorigenesis.
Faculty of Medicine, University of Helsinki • Helsinki, Finland
Conducted research and taught in cancer cell biology.
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.